Marché mondial des substituts sanguins artificiels – Tendances et prévisions de l’industrie jusqu’en 2030

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial des substituts sanguins artificiels – Tendances et prévisions de l’industrie jusqu’en 2030

  • Healthcare
  • Upcoming Reports
  • Dec 2023
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60

Global Artificial Blood Substitutes Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2023 –2030
Diagram Taille du marché (année de référence)
USD 6.67 Million
Diagram Taille du marché (année de prévision)
USD 29.24 Million
Diagram TCAC
%
Diagram Principaux acteurs du marché
  • Aurum Biosciences
  • HEMARINA
  • Hemoglobin Oxygen Therapeutics LLC
  • KaloCyte
  • SpheriTech

Marché mondial des substituts sanguins artificiels, par type de produit (perfluorocarbure (PFC), transporteurs d’oxygène à base d’hémoglobine (HBOC)), source (sang humain, sang animal, HB recombinant à base de micro-organismes, polymères synthétiques, cellules souches), application (maladies cardiovasculaires, néoplasmes malins, blessures, affections néonatales, transplantation d’organes, affection maternelle), utilisateur final (hôpitaux et cliniques, banques de sang, autres) – Tendances et prévisions de l’industrie jusqu’en 2030.

Marché des substituts sanguins artificiels

Analyse et taille du marché des substituts sanguins artificiels

Le sang artificiel est utilisé pour rétablir l'apport d'oxygène après une perte de sang due à un traumatisme, notamment dans les situations d'urgence et sur le champ de bataille, évitant ainsi le recours aux transfusions sanguines pendant une intervention chirurgicale. Il s'agit d'un produit sanguin de substitution capable d'assurer la fonction la plus importante du sang, à savoir le transport de l'oxygène et du dioxyde de carbone . Le sang artificiel pourrait sauver des vies, notamment en cas de perte de sang importante lors de catastrophes majeures. Cependant, les produits actuellement en cours de développement ne sont pas capables d'assurer les fonctions secondaires du sang, comme la lutte contre les infections.

Data Bridge Market Research analyse que le marché mondial des substituts du sang artificiel, qui était de 6,67 millions USD en 2022, devrait atteindre 29,24 millions USD d'ici 2030 et devrait connaître un TCAC de 20,4 % au cours de la période de prévision. « Hôpitaux et cliniques » domine le segment des utilisateurs finaux du marché mondial des substituts du sang artificiel en raison de la demande croissante de meilleures méthodes de diagnostic et de traitement. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Années historiques

2021 (personnalisable pour 2016-2020)

Unités quantitatives

Chiffre d'affaires en millions USD, volumes en unités, prix en USD

Segments couverts

Par type de produit (perfluorocarbures (PFC), transporteurs d'oxygène à base d'hémoglobine (HBOC)), source (sang humain, sang animal, HB recombinant à base de micro-organismes, polymères synthétiques, cellules souches), application (maladies cardiovasculaires, néoplasmes malins, blessures, affections néonatales, transplantation d'organes , affection maternelle), utilisateur final (hôpitaux et cliniques, banques de sang, autres)

Pays couverts

États-Unis, Canada et Mexique en Amérique du Nord, Allemagne, France, Royaume-Uni, Pays-Bas, Suisse, Belgique, Russie, Italie, Espagne, Turquie, Reste de l'Europe en Europe, Chine, Japon, Inde, Corée du Sud, Singapour, Malaisie, Australie, Thaïlande, Indonésie, Philippines, Reste de l'Asie-Pacifique, Arabie saoudite, Émirats arabes unis, Afrique du Sud, Égypte, Israël, Reste du Moyen-Orient et de l'Afrique, Brésil, Argentine et Reste de l'Amérique du Sud

Acteurs du marché couverts

Aurum Biosciences (Royaume-Uni), HEMARINA (France), Hemoglobin Oxygen Therapeutics LLC (États-Unis), KaloCyte Inc. (États-Unis), SpheriTech Ltd. (Royaume-Uni), Centrum Medyczne VisusMed (Pologne), Agence européenne des médicaments (Pays-Bas), OPK Biotech Inc. (États-Unis), NuvOx Pharma (États-Unis), Prolong Pharmaceuticals, LLC (États-Unis), Boston Pharmaceuticals (États-Unis), OXYVITA Inc (États-Unis), NanoBlood LLC (États-Unis)

Opportunités de marché

  • La demande de substituts sanguins artificiels augmente en raison de l'incidence croissante des accidents de la route
  • Prise de conscience croissante des avantages des substituts sanguins artificiels
  • Progrès technologiques dans les opérations de transfusion sanguine

 

Définition du marché

Les substituts sanguins artificiels sont également appelés oxygénothérapie ou transporteurs d'oxygène à base d'hémoglobine. Ils sont utilisés pour simuler la fonction du sang biologique et pour offrir une alternative à la transfusion sanguine. Le sang artificiel est utilisé pour remplacer les transfusions de globules rouges en banque et est conçu pour surmonter des limitations telles que le manque de donneurs de sang, le risque élevé de contamination et la nécessité d'une compatibilité croisée. Les transfusions sanguines allogéniques comportent un certain nombre de risques, notamment la transmission de maladies infectieuses , les réactions transfusionnelles, les lésions pulmonaires aiguës liées à la transfusion, la cicatrisation postopératoire retardée des plaies, l'immunomodulation et le risque de récidive du cancer. Elles offrent la promesse de nouveaux traitements médicaux qui sauveront des vies.

Dynamique du marché mondial des substituts de sang artificiel

Conducteurs

  • Utilisation croissante de substituts sanguins artificiels

Le sang animal, le sang humain, les micro-organismes, l'Hb recombinante, les cellules souches et d'autres sources sont utilisés pour créer du sang artificiel. Le sang artificiel présente plusieurs avantages par rapport au sang humain car il appartient à un groupe sanguin universel et peut être administré aux patients quel que soit leur groupe sanguin. Les substituts du sang artificiel ne provoquent pas non plus de réactions immunologiques. De plus, le substitut du sang artificiel élimine le risque de maladies infectieuses ou de contamination lors de la transfusion et a une durée de conservation plus longue que le sang humain, car il peut être conservé pendant 3 ans à température ambiante ou plus, tandis que le sang humain a une durée de conservation de 42 jours. Le sang artificiel peut être utilisé dans les situations d'urgence et est facilement stocké. C'est également une excellente option pour les patients qui n'acceptent pas le sang des donneurs en raison de leurs croyances religieuses. Ce sont tous des facteurs certains qui propulsent la croissance du marché.

  • Sensibilisation croissante aux avantages du sang artificiel

La prise de conscience croissante des avantages du sang artificiel et la demande croissante de sang artificiel, combinées à un nombre insuffisant de donneurs de sang, stimulent la croissance du marché. La fabrication de substituts sanguins permet de détruire les bactéries et les virus. Cela réduit le risque de maladies infectieuses lors des transfusions sanguines, qui constitue un problème majeur dans de nombreuses régions d'Afrique subsaharienne. L'augmentation de la recherche et du développement sur le sang artificiel stimule le marché mondial des substituts sanguins artificiels.

Opportunité

  • Growing number of surgical procedures

A growing number of surgical procedures necessitate the use of artificial blood substitutes in place of donated human blood plasma or red cells.  Increased funding for research on artificial blood substitutes by government and private organizations, which is likely to result in innovations and new product launches.

Restraints/Challenges

  • High cost of artificial blood substitutes

High cost of artificial blood substitutes and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. For instance, most hemoglobin-based products only last 20-30 hours in the body. In comparison, whole blood transfusions last 34 days. Furthermore, these blood substitutes do not mimic the ability of blood to fight diseases and clot.

This artificial blood substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial blood substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

  • In November 2020, Hemarina published a scientific report on the anti-inflammatory and antibacterial properties of M 101, an oxygen transporter for the treatment of periodontitis. This study validated the quality of M 101 molecule, which is derived from marine lugworm haemoglobin
  • In June 2020, KaloCyte, Inc. received a USD 300,000 grant from the University System of Maryland (USM) Momentum Fund to develop ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has enabled the company to accelerate the development of the ErythroMer
  • In May 2020, KaloCyte, Inc. was awarded a USD 373,000 Small Business Innovation Research (SBIR) Phase I grant by the National Institutes of Health (NIH). This grant assisted the company in advancing the KaloCyte product to preclinical safety and efficacy testing in preparation for market launch

Global Artificial Blood Substitutes Market Scope

The artificial blood substitutes market is segmented on the basis of product type, source, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Perflurocarbon (PFCs)
  • Hemoglobin-Based Oxygen Carries (HBOCs)

 Source

  • Human Blood
  • Animal Blood
  • Microorganism Based Recombinant HB
  • Synthetic Polymers and Stem Cells

 Application

  • Cardiovascular Diseases
  • Malignant Neoplasma
  • Injuries
  • Neonatal Conditions
  • Organ Transplant and Maternal Condition

 End User

  • Hospital and Clinics
  • Blood Banks
  • Others

 Global Artificial Blood Substitutes Market Regional Analysis/Insights

The artificial blood substitutes market is analyzed and market size insights and trends are provided by country, product type, source, application and end user as referenced above.

The countries covered in the artificial blood substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.

North America is expected to dominate the artificial blood substitutes market owing to factors such as a rise in cases of road accidents, increasing prevalence of chronic diseases, and an increase in surgeries due to medical conditions.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to factors such as a rise in diabetes cases coupled with an increase in surgeries related to eye operations resulting from blindness caused by diabetes retinopathy which are major applications for HBOCs used across this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Artificial Blood Substitutes Market Share Analysis

The artificial blood substitutes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to artificial blood substitutes market.

Some of the major players operating in the artificial blood substitutes market are:

  • Aurum Biosciences (U.K.)
  • HEMARINA (France)
  • Hemoglobin Oxygen Therapeutics LLC (États-Unis)
  • KaloCyte Inc. (États-Unis)
  • SpheriTech Ltd. (Royaume-Uni)
  • Centrum Medyczne VisusMed (Pologne)
  • Agence européenne des médicaments (Pays-Bas)
  • OPK Biotech Inc. (États-Unis)
  • NuvOx Pharma (États-Unis)
  • Prolong Pharmaceuticals, LLC (États-Unis)
  • Boston Pharmaceuticals (États-Unis)
  • OXYVITA Inc (États-Unis)
  • NanoBlood LLC (États-Unis)


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. Currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. primary interviews with key opinion leaders
    7. MULTIVARIATE MODELLING
    8. PRODUCT TYPE LIFELINE CURVE
    9. DBMR MARKET POSITION GRID
    10. market APPLICATION coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. PATENT ANALYSIS OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. DBMR ANALYSIS
    2. COUNTRY-LEVEL ANALYSIS
    3. YEARWISE ANALYSIS
  6. GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS
  7. Market Overview
    1. drivers
      1. IncreasE IN demand for blood transfusion
      2. Increased funding for product development
      3. rise in blood-related disorders and trauma cases
      4. limited availability of fresh blood and small storage periods of fresh blood
    2. Restraints
      1. stringent regulatory approval process
      2. high-cost production of artificial blood substitute
      3. unawareness about the artificial blood substitutes
    3. OPPORTUNITIES
      1. increase in awareness regarding the advantages of artificial blood over human blood
      2. risE IN demand for blood substituteS and insufficient number of blood donors
      3. RISE IN number of research & developments on artificial blood
      4. ample amount of sources for production of artificial blood substitute
    4. Challenges
      1. instability of artificial blood product
      2. extended clinical trails
      3. side effects of artificial blood substitutes
  8. IMPACT OF COVID-19 ON THE GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. Aftermath of COVID-19
    2. Impact on Supply and Demand
    3. The increasing demand for blood transfusion is leading the artificial blood substitutes market.
    4. Conclusion
  9. Global Artificial blood substitutes market, by Product Type
    1. overview
    2. Hemoglobin-Based Oxygen Carries (HBOCS)
      1. oxyglobin
      2. hemopure
    3. Perfluorocarbon (PFCS)
      1. perftoran
      2. others
  10. Global Artificial blood substitutes market, by Source
    1. overview
    2. animal blood
    3. Human Blood
    4. Microorganism Based Recombinant Hb
    5. Stem Cells
    6. Synthetic Polymers
  11. Global Artificial blood substitutes market, by Application
    1. overview
    2. injuries
    3. Cardiovascular Diseases
    4. Organ Transplant
    5. Maternal Condition
    6. Malignant Neoplasma
    7. Neonatal Conditions
  12. Global Artificial blood substitutes market, by End user
    1. overview
    2. hospital and clinics
    3. blood banks
    4. others
  13. Global Artificial blood SUBSTITUTEs MARKET, by Region
    1. Overview
    2. NORTH AMERICA
      1. U.S.
      2. MEXICO
    3. Middle East & Africa
      1. South Africa
      2. Rest Of Middle East & Africa
    4. EUROPE
      1. FRANCE
      2. RUSSIA
      3. NETHERLAND
      4. U.K.
      5. REST OF EUROPE
    5. asia-pacific
      1. China
      2. Rest Of asia-pacific
  14. global artificial blood substitutes market: COMPANY landscape
    1. company share analysis: Global
    2. global artificial blood substitutes market: company share 2020 (%)
    3. company share analysis: North America
    4. North America artificial blood substitutes market: company share 2020 (%)
    5. company share analysis: Europe
    6. Europe artificial blood substitutes market: company share 2020 (%)
  15. swot
  16. company profile
    1. kalocyte, inc.
      1. COMPANY SNAPSHOT
      2. Company sahre Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    2. hemarina
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    3. hemoglobin oxygen therapeutics llc
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    4. llc “visusmed”
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    5. European Medicines Agency
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. company share analysis
      4. PRODUCT PORTFOLIo
      5. RECENT DEVELOPMENT
    6. aurum biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    7. boston therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    8. nanoblood llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    9. nuvox pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    10. opk biotech llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    11. oxyvita inc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    12. prolong pharmaceuticals, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

Liste des tableaux

TABLE 1 global Artificial blood substitutes Market, Product Type, 2019-2028 (USD Thousand)

TABLE 2 global Hemoglobin-Based Oxygen Carries (HBOCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 3 global HEMOGLOBIN-based oxygen carriers (HBOCs) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 4 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 5 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 6 global Artificial blood substitutes Market, by Source, 2019-2028 (USD Thousand)

TABLE 7 global animal blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 8 global human blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 9 global microorganism based recombinant hb in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 10 global stem cells in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 11 global synthetic polymers in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 12 global Artificial blood substitutes Market, by Application, 2019-2028 (USD Thousand)

TABLE 13 global injuries in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 14 global cardiovascular diseases in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 15 global organ transplant in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 16 global maternal condition in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 17 global malignant neoplasma in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 18 global neonatal conditions in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 19 global Artificial blood substitutes Market, by End user, 2019-2028 (USD Thousand)

TABLE 20 global hospitals and clinics in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 21 global blood banks in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 22 global others in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 23 GLOBAL Artificial blood substitutes MARKET, BY REGION, 2021-2028 (USD THOUSAND)

TABLE 24 North AMERICA Artificial blood substitutes Market, By country, 2019-2028 (USD Thousand)

TABLE 25 NORTH AMERICA Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 26 North America Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 27 North America Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 28 North America Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 29 North America Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 30 North America Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 31 U.S. Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 32 U.S. Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 33 U.S. Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 34 U.S. Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 35 U.S. Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 36 U.S. Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 37 MEXICO Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 38 MEXICO Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 39 MEXICO Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 40 MEXICO Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 41 MEXICO Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 42 MEXICO Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 43 Middle East & Africa artificial blood substitutes market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 44 Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 45 Middle East & Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 46 Middle East & Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 47 Middle East & Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)

TABLE 48 Middle East & Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)

TABLE 49 Middle East & Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)

TABLE 50 South Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 51 South Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 52 South Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 53 South Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)

TABLE 54 South Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)

TABLE 55 South Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)

TABLE 56 rest of Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 57 Europe artificial blood substitute Market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 58 EUROPE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 59 Europe Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 60 Europe Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 61 Europe artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 62 Europe artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 63 Europe artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 64 FRANCE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 65 FRANCE Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 66 FRANCE Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 67 FRANCE artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 68 FRANCE artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 69 FRANCE artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 70 RUSSIA artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 71 RUSSIA Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 72 RUSSIA Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 73 RUSSIA artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 74 RUSSIA artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 75 RUSSIA artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 76 NETHERLAND artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 77 NETHERLAND Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 78 NETHERLAND Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 79 NETHERLAND artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 80 NETHERLAND artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 81 NETHERLAND artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 82 U.K. artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 83 U.K. Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 84 U.K. Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 85 U.K. artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 86 U.K. artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 87 U.K. artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 88 REST OF EUROPE ARTIFICIAL blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 89 Asia-Pacific artificial blood substitute market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 90 asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 91 asia-pacific Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 92 asia-pacific perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 93 asia-pacific artificial blood substitute market, By Source, 2019-2028 (USD thousand)

TABLE 94 asia-pacific artificial blood substitute market, By application, 2019-2028 (USD thousand)

TABLE 95 asia-pacific artificial blood substitute market, By end user, 2019-2028 (USD thousand)

TABLE 96 China artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 97 China Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 98 China perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 99 China artificial blood substitute market, By Source, 2019-2028 (USD thousand)

TABLE 100 China artificial blood substitute market, By application, 2019-2028 (USD thousand)

TABLE 101 China artificial blood substitute market, By end user, 2019-2028 (USD thousand)

TABLE 102 rest of asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)

Liste des figures

FIGURE 1 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: segmentation

FIGURE 2 global artificial blood substitutes market: data triangulation

FIGURE 3 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS

FIGURE 4 Global artificial blood substitutes market: GLOBAL vs REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: market APPLICATION COVERAGE GRID

FIGURE 9 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 11 north america is expected to DOMINATE THE global artificial blood substitutes market AND GROWing WITH THE HIGHEST share IN the forecast period of 2021 To 2028

FIGURE 12 increased DEMAND FOR BLOOD TRANSFUSION is expected to drive the global artificial blood substitutes market in THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 haemoglobin-based oxygen carriers (hbocs) SEgment is expected to account for the largest share of the GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET in 2021 & 2028

FIGURE 14 north america is the fastest growing market for artificial blood substitutes manufacturers in the forEcast period of 2021 to 2028

FIGURE 15 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY

FIGURE 16 PATENT REGISTERED YEAR (2017 - 2021)

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF GLOBAL artificial blood substituteS MARKET

FIGURE 18 global Artificial blood substitutes Market, By Product Type, 2020

FIGURE 19 global Artificial blood substitutes Market, By Source, 2020

FIGURE 20 global Artificial blood substitutes Market, By Application, 2020

FIGURE 21 global Artificial blood substitutes Market, By End user, 2020

FIGURE 22 GLOBAL Artificial blood substitutes market: SNAPSHOT (2020)

FIGURE 23 GLOBAL Artificial blood substitutes market: BY REGION (2020)

FIGURE 24 GLOBAL Artificial blood substitutes market: BY REGION (2021 & 2028)

FIGURE 25 GLOBAL Artificial blood substitutes market: BY REGION (2020 & 2028)

FIGURE 26 GLOBAL Artificial blood substitutes market: BY Product Type (2021-2028)

FIGURE 27 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: SNAPSHOT (2020)

FIGURE 28 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020)

FIGURE 29 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 30 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 31 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY product type (2021-2028)

FIGURE 32 Middle East & Africa artificial blood substitutes market: SNAPSHOT (2020)

FIGURE 33 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020)

FIGURE 34 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2021 & 2028)

FIGURE 35 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020 & 2028)

FIGURE 36 Middle East & Africa artificial blood substitutes market: BY PRODUCT TYPE (2021 & 2028)

FIGURE 37 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: SNAPSHOT (2020)

FIGURE 38 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020)

FIGURE 39 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY product type (2021-2028)

FIGURE 42 Asia-Pacific artificial blood substitute market: SNAPSHOT (2020)

FIGURE 43 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020)

FIGURE 44 Asia-Pacific artificial blood substitute market: BY COUNTRY (2021 & 2028)

FIGURE 45 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020 & 2028)

FIGURE 46 Asia-Pacific artificial blood substitute market: BY product TYPE (2020 & 2028)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The market is segmented based on , By Product Type (Perflurocarbon (PFCs), Hemoglobin-Based Oxygen Carries (HBOCs)), Source (Human Blood, Animal Blood, Microorganism Based Recombinant HB, Synthetic Polymers, Stem Cells), Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), End User (Hospital and Clinics, Blood Banks, Others) – Industry Trends and Forecast to 2030. .
The Global Artificial Blood Substitutes Market size was valued at USD 6.67 USD Million in 2022.
The Global Artificial Blood Substitutes Market is projected to grow at a CAGR of 20.4% during the forecast period of 2023 to 2030.
The major players operating in the market include Aurum Biosciences, HEMARINA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte , SpheriTech , Centrum Medyczne VisusMed, European Medicines Agency, OPK Biotech , NuvOx Pharma, Prolong Pharmaceuticals LLC, Boston Pharmaceuticals, OXYVITA , NanoBlood LLC.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.